| Financial Year |
March 31 2023 |
| Monetary Funds |
3,666,442,508.43 |
| Held-for-trading Financial Assets |
-- |
| Notes Receivable |
1,000,000.00 |
| Accounts Receivable |
387,604,271.11 |
| Advances to Suppliers |
133,798,832.98 |
| Other Receivables |
11,194,286.22 |
| Amounts Due From Related Companies |
-- |
| Interest Receivable |
-- |
| Dividend Receivable |
-- |
| Inventories |
479,546,202.10 |
| Among: Consumptive Biological Assets |
-- |
| Non-Current Assets Maturing Within One Year |
-- |
| Other Current Assets |
77,326,474.04 |
| Total Current Assets |
5,640,142,468.66 |
| Available-for-Sale Financial Asset |
-- |
| Held-to-maturity Investments |
-- |
| Long-Term Account Receivable |
-- |
| Long-term Equity Investment |
-- |
| Investment Properties |
26,985,414.78 |
| Fixed Assetes |
10,383,862,457.87 |
| Under-construction Projects |
1,614,125,694.87 |
| Construction Materials |
-- |
| Disposal of Fixed Assets |
-- |
| Capitalized Biological Assets |
-- |
| Oil and Gas Assets |
-- |
| Intangible Assets |
1,316,746,938.50 |
| R&D expenses |
-- |
| Goodwill |
-- |
| Long-Term Deferred and Prepaid Expenses |
-- |
| Deferred Income Tax Assets |
753,549,713.82 |
| Other Non-Current Assets |
5,824,923.21 |
| Sub-Total of Non-Current Assets |
14,399,598,191.25 |
| Total Assets |
20,039,740,659.91 |
| Short-Term Loans |
-- |
| Trading Financial liabilities |
-- |
| Notes Payable |
68,372,913.97 |
| Accounts Payable |
1,220,584,117.07 |
| Accounts Received In Advance |
-- |
| Employee Compensation Payable |
1,044,687,338.22 |
| Taxes Payable |
818,713,628.37 |
| Interest Payable |
6,226,762.77 |
| Dividend Payable |
-- |
| Other payables |
527,265,771.35 |
| Due to Related Companies |
-- |
| Non-Current Liabilities Due Within One Year |
78,180,526.76 |
| Other Current Liabilities |
25,084,678.48 |
| Sub-Total of Current Liabilities |
3,977,936,180.62 |
| Long-term Loans |
1,032,000,000.00 |
| Bonds Payable |
-- |
| Long-Term Accounts Payable |
496,814,929.28 |
| Special Payable |
-- |
| Estimatied Liabilities |
959,442,763.09 |
| Deferred Income Tax Liabilities |
-- |
| Other Non-Current Liabilities |
179,380,233.46 |
| Sub-Total of Non-Current Liabilities |
3,007,476,870.89 |
| Total Liabilities |
6,985,413,051.51 |
| Paid-In Capital(Or Share Stock) |
722,718,000.00 |
| Capital Surplus |
916,979,701.34 |
| Surplus Reserve |
361,359,000.00 |
| LESS:Treasury Stock |
-- |
| Undistributed Profits |
10,676,378,479.04 |
| Minority Stockholder's Interest |
17,134,145.80 |
| Foreign Currency Capital |
-- |
| Abnormal Management Project Income Adjusted |
-- |
| Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
13,037,193,462.60 |
| Owner's Equity（Stockholder's Equity） |
13,054,327,608.40 |
| Total Liabilities and Owner's Equity（Stockholder's Equity） |
20,039,740,659.91 |
